Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
[
Type
]
Year
Filters:
Author
is
Logan, Aaron C
[Clear All Filters]
Journal Article
Waller EK
,
Miklos D
,
Cutler C
,
Arora M
,
Jagasia MH
,
Pusic I
,
Flowers MED
,
Logan AC
,
Nakamura R
,
Chang S
, et al.
Ibrutinib for Chronic Graft-Versus-Host Disease After Failure of Prior Therapy: 1-Year Update of a Phase 1b/2 Study.
Biol Blood Marrow Transplant. 2019.
PubMed
Google Scholar
Shah BD
,
Cassaday RD
,
Park JH
,
Houot R
,
Oluwole OO
,
Logan AC
,
Boissel N
,
Leguay T
,
Bishop MR
,
Topp MS
, et al.
Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.
J Immunother Cancer. 2023;11(8).
PubMed
Google Scholar
Shah BD
,
Ghobadi A
,
Oluwole OO
,
Logan AC
,
Boissel N
,
Cassaday RD
,
Leguay T
,
Bishop MR
,
Topp MS
,
Tzachanis D
, et al.
KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study.
Lancet. 2021.
PubMed
Google Scholar
Gaut D
,
Oliai C
,
Boiarsky J
,
Zhang S
,
Salhotra A
,
Azenkot T
,
Kennedy VE
,
Khanna V
,
Gutierrez KOlmedo
,
Shukla N
, et al.
Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia.
Leuk Lymphoma. 2023:1-9.
PubMed
Google Scholar